View in EDS

A phase II randomized open-label study anti-CMV hyperimmune globulin vs standard IGIV for prevention of cytomegalovirus (CMV) reactivation in hypogammaglobulinemic adult allogeneic hematopoietic stem cell transplants (AHSCT)

Saved in:
Bibliographic Details
Title: A phase II randomized open-label study anti-CMV hyperimmune globulin vs standard IGIV for prevention of cytomegalovirus (CMV) reactivation in hypogammaglobulinemic adult allogeneic hematopoietic stem cell transplants (AHSCT)
Authors: Bubalo, J.S.1, Leis, J.F.1, Curtin, P.T.1, Simic, A.1, Subbiah, N.1, Fowler, C.1, Dunn, A.1, Grant, B.1, Maziarz, R.T.1
Source: Biology of Blood & Marrow Transplantation. Feb2006 Supplement 1, Vol. 12, p170-170. 1p.
Database: Academic Search Ultimate
Description
ISSN:10838791
DOI:10.1016/j.bbmt.2005.12.015